HK-listed GenFleet jumps on positive progress of cancer drug
15/10/2026 04:06
BUZZ-HK-listed GenFleet jumps on positive progress of cancer drug ** Shares of China-based innovative drugs developer GenFleet Therapeutics (Shanghai) Inc 2595.HK jump 8.4% to HK$28.54, on track for the biggest one-day pct gain since September 30
** Stock touches highest level since October 12, snapping three straight sessions of losses
** GenFleet announces positive progress in GFH375/VS-7375's clinical development for cancer treatment with latest data disclosed from multiple clinical studies in China and abroad reflecting promising efficacy in various ras sarcoma-mutant solid tumors
** YTD, stock up 14.7%, Hang Seng Biotech Index .HSBIO up 5.2%
(Reporting by Donny Kwok)
Recent news on GenFleet Therapeutics (Shanghai)
See all newsHK-listed GenFleet jumps on positive progress of cancer drug
GenFleet hits over 3-week high as cancer drug makes progress on BTD list
Brief: GenFleet Therapeutics (Shanghai) Says GFH375 Combined With Cetuximab Placed On Proposed BTD List
HK-listed GenFleet rises most in a month on repurchasing shares
Brief: GenFleet Therapeutics (Shanghai) Reports Loss Of RMB220.17 Million For Six Months